Precision prescribing used to be a trending vision; now it's a necessary reality. Gustavo Bernard Esquivel, MD, Ph.D., MHA Chief Medical Officer, GenXys Health Care Systems, provides his views in this article.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
